Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cocrystal Pharma Inc (NQ: COCP )

2.150 +0.090 (+4.37%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,667
Open 2.040
Bid (Size) 2.140 (3)
Ask (Size) 2.160 (3)
Prev. Close 2.060
Today's Range 2.001 - 2.200
52wk Range 1.325 - 3.100
Shares Outstanding 10,173,790
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Toll Brothers To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga

Performance

YTD
+22.31%
+22.31%
1 Month
+2.38%
+2.38%
3 Month
+12.57%
+12.57%
6 Month
+0.94%
+0.94%
1 Year
+31.90%
+31.90%

More News

Read More
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
Via ACCESSWIRE
COCP Stock Earnings: Cocrystal Pharma Misses EPS for Q2 2024
Via InvestorPlace
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024
Via InvestorPlace
Recap: Cocrystal Pharma Q4 Earnings
Via Benzinga
Recap: Cocrystal Pharma Q3 Earnings
Via Benzinga
Analyst Ratings for Cocrystal Pharma
Via Benzinga
Why Cocrystal Pharma Shares Are Trading Higher Today
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023
Via InvestorPlace
Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
$2M Bet On Cocrystal Pharma? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Why Pioneer Natural Resources Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Cocrystal Pharma Discusses Clinical Progress and Significance of Its Novel Antiviral Therapeutics Pipeline with The Stock Day Podcast
Via Newsfile
Exposures COVID-19
Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022
From Cocrystal Pharma, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Cocrystal Pharma Posts Favorable Safety Data From Oral Antiviral Against Influenza A
Via Benzinga
Cocrystal Pharma Announces Favorable Safety Data from the Phase 1 Study with Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A
From Cocrystal Pharma, Inc.
Via GlobeNewswire
Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
From Cocrystal Pharma, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.